SEARCH

SEARCH BY CITATION

References

  • 1
    Babaian RJ, Camps JL, Frangos DN et al. Monoclonal prostate-specific antigen in untreated prostate cancer: Relationship to clinical stage and grade. Cancer 1991; 67: 22002206.
  • 2
    Lee F, Torp-Pedersen S, Littrup PJ et al. Hypoechoic lesions of the prostate: Clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen. Radiology 1989; 170: 2932.
  • 3
    Catalona WJ, Smith DS, Ratliff TL et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991; 324: 11561161.
  • 4
    Babaian RJ, Miyashita H, Evans RB, Ramirez EI. The distribution of PSA in men without clinical or pathologic evidence of prostate cancer: Relationship to gland volume and age. J Urol (in press).
  • 5
    Thompson IM, Ernst JJ, Gangai MP, Spence CR. Adenocarcinoma of the prostate: Results of routine urological screening. J Urol 1984; 132: 690692.
  • 6
    Lee F, Littrup PJ, Torp-Pedersen ST et al. Prostate cancer: Comparison of transrectal US and digital rectal examination for screening. Radiology 1988; 168: 389394.
  • 7
    Murphy GP, Natarajan N, Pontes JE et al. The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol 1982; 127: 928938.
  • 8
    Schmidt JD, Mettlin C, Natarajan N et al. Trends in patterns of care for prostate cancer 1973–1983: Results of surveys by the American College of Surgeons. J Urol 1986; 136: 416421.
  • 9
    Mettlin C, Lee F, Drago J, Murphy GP. the members of the American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men. Cancer 1991; 67: 29492958.
  • 10
    Babaian RJ, Camps JL. The role of prostate-specific antigen as part of the diagnostic triad and as a guide when to biopsy. Cancer (in press).
  • 11
    Oesterling JE. Prostate-specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991; 145: 907923.
  • 12
    Glantz SA. How to test for differences between groups: How to analyze rates and proportions. In: GlantzSA, ed. Primer of Bio-statistics, ed. 2. New York: McGraw-Hill, 1987; 3058, 122–131.
  • 13
    Babaian RJ, Miyashita H, Evans RB, von Eschenbach AC, Ramirez EI. Early detection program for prostate cancer: Results and identification of high-risk patient populations. Urology 1991; 37: 193197.
  • 14
    Cooner WH, Mosley BR, Rutherford CL Jr et al. Prostate-cancer detection in a clinical urological practice by ultrasonography, digital rectal examination, and prostate specific antigen. J Urol 1990; 143: 11461152.